Phase I and pharmacokinetic study of BIBX 1382 BS, an epidermal growth factor receptor (EGFR) inhibitor, given in a continuous daily oral administration (Q43991568)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I and pharmacokinetic study of BIBX 1382 BS, an epidermal growth factor receptor (EGFR) inhibitor, given in a continuous daily oral administration |
scientific article |
Statements
1 reference
Phase I and pharmacokinetic study of BIBX 1382 BS, an epidermal growth factor receptor (EGFR) inhibitor, given in a continuous daily oral administration (English)
1 reference
Ch Dittrich
1 reference
G Greim
1 reference
M Borner
1 reference
K Weigang-Köhler
1 reference
H Huisman
1 reference
A Amelsberg
1 reference
A Ehret
1 reference
J Wanders
1 reference
A Hanauske
1 reference
P Fumoleau
1 reference
1 May 2002
1 reference
1 reference
Identifiers
1 reference